Prismaflex systems with risk of under infusion of anticoagulant


Manufactured by Baxter – the software fails to save the syringe type and size in service and custom modes, and so reverts to default settings” MHRA (2017).


  • Identify affected devices.
    Ensure that:
  • users understand the problem detailed in the Field Safety Notice and follow the manufacturer’s advice
  • Have systems in place to ensure the upgrade is undertaken as soon as possible or at least by the next planned annual maintenance service.
  • Baxter will contact users to schedule the software upgrade of your devices to rectify the issue.
  • Return the Field Safety Notice acknowledgement form to Baxter as currently the manufacturer hasn’t received enough responses.
Full Text

Thank you to our partners for supporting IVTEAM


Comments are closed.